Phase III Trial of Anlotinib, Catequentinib in Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma (APROMISS)
Clinical trial NCT03016819 · RECRUITING
Trial details
- NCT number
- NCT03016819
- Sponsor
- Advenchen Laboratories, LLC
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-15
- Primary completion
- 2027-12-01
- Enrollment
- 325
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.